Form 4: Director John Kennedy Receives Gentex Equity Grant

Gentex Corporation director John Kennedy was granted 5,626 shares of common stock as part of a standard equity compensation award.

Summary

• Director John C. Kennedy acquired 5,626 shares of Gentex Corporation (GNTX) common stock.
• The transaction occurred on May 21, 2026.
• The shares were granted at a price of $0.00, representing an equity compensation award.
• The shares are subject to a 100% vesting schedule one year from the grant date.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation.

Positives

• Alignment of director interests with shareholders through equity-based compensation.
• Standardized compensation practice for board members.

Negatives

• None identified; this is a routine equity grant.

Risks

• None identified; this is a routine equity grant.

Future Outlook

The shares vest 100% one year from the grant date, indicating a long-term retention incentive for the director.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practices in the automotive technology sector to ensure board members maintain a vested interest in company performance.

Comparison to Industry Standards

• The grant aligns with standard compensation practices for directors at mid-to-large cap automotive suppliers.
• Vesting schedules of one year are consistent with typical board compensation structures.

Corporate Governance

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity compensation award.

Next Steps

• Vesting of the 5,626 shares on May 21, 2027.

Key Dates

Keywords

GNTX, Gentex Corporation, Form 4, Director Compensation, Insider Transaction, Equity Grant